Outlook Therapeutics Ownership | Who Owns Outlook Therapeutics?

Overview Forecast RevenueFinancials Chart

Outlook Therapeutics Ownership Summary

Outlook Therapeutics is owned by 17.81% institutional investors, 15.52% insiders, and 66.66% retail investors. Armistice capital is the largest institutional shareholder, holding 6.92% of OTLK shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.07% of its assets in Outlook Therapeutics shares.

OTLK Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Outlook Therapeutics	17.81%	15.52%	66.66%
Sector	Healthcare Stocks	35.56%	12.08%	52.36%
Industry	Biotech Stocks	35.43%	12.01%	52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Armistice capital	4.17M	6.92%	$857.77K
Vanguard group	1.47M	4.21%	$2.31M
Geode capital management	603.61K	1.00%	$124.23K
Blackrock funding, inc. /de	477.47K	0.79%	$98.26K
Warberg asset management	275.00K	0.46%	$56.38K
Renaissance	255.16K	0.42%	$52.51K
Nine masts capital	232.55K	0.39%	$47.86K
Connective capital management	200.00K	0.33%	$41.16K
Vanguard fiduciary trust	176.53K	0.29%	$36.37K
State street	163.10K	0.27%	$33.57K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Connective capital management	200.00K	0.03%	$41.16K
Armistice capital	4.17M	0.02%	$857.77K
Warberg asset management	275.00K	0.01%	$56.38K
Nine masts capital	232.55K	0.01%	$47.86K
Two sigma securities	35.66K	0.01%	$37.80K
Christensen, king & associates investment services	28.33K	0.00%	$5.83K
Flower city capital	20.00K	0.00%	$4.12K
Point72 asia (singapore) pte.	5.82K	0.00%	$6.16K
Virtu financial	112.79K	0.00%	$23.00K
Xtx topco	52.99K	0.00%	$10.91K

Top Buyers

Holder	Shares	% Assets	Change
Armistice capital	4.17M	0.02%	4.17M
Geode capital management	603.61K	-	287.14K
Warberg asset management	275.00K	0.01%	275.00K
Renaissance	255.16K	0.00%	255.16K
Nine masts capital	232.55K	0.01%	232.55K

Top Sellers

Holder	Shares	% Assets	Change
Schonfeld strategic advisors	-	-	-2.44M
Sphera funds management	-	-	-857.14K
Commonwealth equity services	-	-	-470.00K
Rosalind advisors	-	-	-450.00K
Tang capital management	-	-	-400.00K

New Positions

Holder	Shares	% Assets	Change	Value
Armistice capital	4.17M	0.02%	4.17M	$857.77K
Warberg asset management	275.00K	0.01%	275.00K	$56.38K
Renaissance	255.16K	0.00%	255.16K	$52.51K
Nine masts capital	232.55K	0.01%	232.55K	$47.86K
Connective capital management	200.00K	0.03%	200.00K	$41.16K

Sold Out

Holder	Change
Barclays	-1.00
True wealth design	-20.00
Ifp advisors	-50.00
Corecap advisors	-62.00
Tradewinds capital management	-100.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	59	-3.28%	10,725,391	57.24%	17	13.88%	32	-	8	14.29%
Dec 31, 2025	13	-77.59%	1,856,635	-54.47%	5	4.38%	7	-69.57%	-	-100.00%
Sep 30, 2025	16	-73.77%	1,609,381	-69.77%	4	1.46%	8	-75.00%	4	-75.00%
Jun 30, 2025	64	1.59%	5,935,574	-16.22%	19	3.65%	33	-13.16%	18	38.46%
Mar 31, 2025	63	3.28%	7,084,425	64.93%	22	7.30%	38	8.57%	13	8.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	3.07M	2.07%	2.13M
Vanguard US Total Market Shares ETF	442.51K	1.38%	-
Vanguard Institutional Extnd Mkt Idx Tr	1.23M	0.83%	406.04K
CREF Stock R1	100.34K	0.42%	65.13K
Fidelity Small Cap Index	169.90K	0.40%	-6.23K
Federated Hermes MDT SCG Institutional	88.30K	0.37%	88.30K
Federated Hermes MDT Small Cap Growth IS	88.30K	0.37%	88.30K
Fidelity Extended Market Index	382.68K	0.26%	-
iShares Russell 2000 Growth ETF	100.13K	0.23%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	66.90K	0.21%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 29, 2026	Sukhtian Faisal Ghiath	-	Buy	$100.00K
Jun 02, 2026	Haddadin Yezan Munther	-	Buy	$24.15K
May 28, 2026	Sukhtian Ghiath M.		Buy	$5.02M
May 28, 2026	Sukhtian Ghiath M.		Buy	$2.02M
May 28, 2026	Sukhtian Ghiath M.		Buy	$5.00M

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	1	-
2026 Q2	8	-
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-

OTLK Ownership FAQ

Who Owns Outlook Therapeutics?

Outlook Therapeutics shareholders are primarily institutional investors at 17.81%, followed by 15.52% insiders and 66.67% retail investors. The average institutional ownership in Outlook Therapeutics's industry, Biotech Stocks , is 35.43%, which Outlook Therapeutics falls below.

Who owns the most shares of Outlook Therapeutics?

Outlook Therapeutics’s largest shareholders are Armistice capital (4.17M shares, 6.92%), Vanguard group (1.47M shares, 4.21%), and Geode capital management (603.61K shares, 1.00%). Together, they hold 12.14% of Outlook Therapeutics’s total shares outstanding.

Does Blackrock own Outlook Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Outlook Therapeutics.

Who is Outlook Therapeutics’s biggest shareholder by percentage of total assets invested?

Connective capital management is Outlook Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 200K Outlook Therapeutics shares, valued at 41.16K$.

Who is the top mutual fund holder of Outlook Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Outlook Therapeutics shares, with 2.07% of its total shares outstanding invested in 3.07M Outlook Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools